Intest Res.  2020 Apr;18(2):141-143. 10.5217/ir.2020.00022.

Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?

• Cha JM

• KMID: 2501379
• DOI: http://doi.org/10.5217/ir.2020.00022

Reference

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med. 1993; 328:246–252.

2. Cassileth BR. Complementary therapies: the American experience. Support Care Cancer. 2000; 8:16–23.

3. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280:1569–1575.

4. Zezos P, Nguyen GC. Use of complementary and alternative medicine in inflammatory bowel disease around the world. Gastroenterol Clin North Am. 2017; 46:679–688.

5. Abitbol V, Lahmek P, Buisson A, et al. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey. Eur J Gastroenterol Hepatol. 2014; 26:288–294.

6. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17:655–662.

7. Rawsthorne P, Clara I, Graff LA, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut. 2012; 61:521–527.

8. Lee SH, Chang K, Seo KS, et al. Changes in prevalence and perception of complementary and alternative medicine use in Korean inflammatory bowel disease patients: results of an 8-year follow-up survey. Intest Res. 2020; 18:192–199.

9. Park DI, Cha JM, Kim HS, et al. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea. Complement Ther Med. 2014; 22:87–93.

10. Kim SB, Park SJ, Chung SH, et al. Vaccination and complementary and alternative medicine in patients with inflammatory bowel disease. Intest Res. 2014; 12:124–130.